Latest Articles

Publication Date
Women with Endometriosis Face Higher Risk of Autoimmune Diseases - wehavekids.com

Women with Endometriosis Face Higher Risk of Autoimmune Diseases wehavekids.com

Published: May 4, 2025, 12:45 a.m.
Women with Endometriosis Face Higher Risk of Autoimmune Diseases - Yahoo

Women with Endometriosis Face Higher Risk of Autoimmune Diseases Yahoo

Published: May 4, 2025, 12:45 a.m.
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort - BioSpace

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort BioSpace

Published: April 30, 2025, 5:52 a.m.
N-acetylcysteine stimulates organelle malfunction in endometriotic cells via IFN-gamma signaling - Nature

N-acetylcysteine stimulates organelle malfunction in endometriotic cells via IFN-gamma signaling Nature

Published: April 30, 2025, 12:26 a.m.
Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial - marketscreener.com

Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial marketscreener.com

Published: April 28, 2025, 9:23 a.m.
The fight to save Advanced Placement programs - WJCT News 89.9

The fight to save Advanced Placement programs WJCT News 89.9

Published: April 23, 2025, 3 p.m.
On Wednesday’s show: The fight to save Advanced Placement programs - WJCT News 89.9

On Wednesday’s show: The fight to save Advanced Placement programs WJCT News 89.9

Published: April 22, 2025, 4:45 p.m.
Proteomics International Secures $4.5M Placement - Sharecafe

Proteomics International Secures $4.5M Placement Sharecafe

Published: April 22, 2025, 6:55 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
IBS and endometriosis patients could face delays due to NHS waiting list changes - The i Paper

IBS and endometriosis patients could face delays due to NHS waiting list changes The i Paper

Published: April 17, 2025, 4:15 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!